Jared Ament, M.D., M.P.H.
Dr. Jared Ament is a neurosurgeon who is currently affiliated with Cedars-Sinai Marina del Rey Hospital. He received his medical degree from the Medical School for International Health, a collaborative initiative between Columbia University and Ben-Gurion University in Israel. The physician completed his surgical internship at the University of Massachusetts and his graduate studies and post-doctoral fellowship at Harvard. Dr. Jared Ament underwent his neurosurgical training at the University of California, Davis, and completed a complex spine fellowship under Dr. J. Patrick Johnson at Cedars-Sinai Medical Center. He focuses on complex brain and spine surgery, as well as facial pain syndromes. The surgeon has approximately 10 years of professional experience. His subspecialties are the treatment of brain and spinal tumors, neurosurgical spine surgery, and clinical informatics. In 2013, Dr. Jared Ament was part of the team of the clinical trial known as Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC (INTREPID2566), which was led by Ross R Bullock, M.D., Ph.D.
Procedures Dr. Jared Ament Performs at Cedars-Sinai Marina del Rey Hospital
- Blue Shield of California
- CareFirst BCBS
Education & Training
Ben Gurion University of the Negev
University of Massachusetts
University of California, Davis
Cedars-Sinai Medical Center
Memberships & Affiliations
Publications & Media
Reduction of direct costs in high-risk lumbar discectomy patients during the 90-day postoperative period through annular closure.
Thaci, B., McGirt, M., Ammerman, J.M., Thomé, C., Kim, K.D., Ament, J.D.; ClinicoEconomics and Outcomes Research. 2019
Postoperative direct healthcare costs of lumbar discectomy are reduced with the use of a novel annular closure device in high-risk patients.
Ament, J.D., Thaci, B., Yang, Z., Kursumovic, A., Bostelmann, R., Lanman, T., Patrick, J.J., Fröhlich, S., Kim, K.D.; Spine J. 2019
Treatment of Cervical Radiculopathy: A Review of The Evolution and Economics.
Ament, J.D., Karnati, T., Kulubya, E., Kim, K.D., Johnson, J.P.; Surg Neurol Int 2018
Cost-Effectiveness of Endoscopic Versus Microscopic Transsphenoidal Surgery for Pituitary Adenoma.
Ament, J.D., Yang, Z., Khatchadourian, V., Strong, E.B., Shahlaie, K.; World Neurosurg. 2017
Standardizing cost-utility analysis in neurosurgery.
Ament, J.D., Kim, K.D.; Neurosurg Focus 2012
Transient extremity ischemia augments CD34+ progenitor cell availability.
Czeiger, D., Porat, Y., Dukhno, O., Shimoni, D., Ament, J., Douvdevani, A., Shaked, G.; Stem Cell Reviews & Reports. 2011
Risk factors for the development of retroprosthetic membranes with Boston keratoprosthesis type 1: multicenter study results.
Rudnisky, C.J., Belin, M.W., Todani, A., Al-Arfaj, K,, Ament, J.D., Zerbe, B.J., Ciolino, J.B., Boston Type 1 Keratoprosthesis Study Group; Ophthalmology 2012
The Cost-effectiveness of the type II Boston Keratoprosthesis.
Ament, J.D., Stryjewski, T.P., Siddique, S., Pujari, S., Papliodus, G., Chodosh, J., Dohlman, C.H.; Eye (A Nature Journal) 2010
Role for ipsilateral autologous corneas as a carrier for the Boston keratoprosthesis: the Africa experience.
Ament, J.D., Tilahun, Y., Mudawi, E., Pineda, R.; Arch Ophthalmol. 2010
Global corneal blindness and the Boston keratoprosthesis.
Ament, J.D., Todani, A., Pineda, R., Shen, T.T., Aldave, A., Dohlman, C.H., Chodosh, C.; Am J Ophthalmol. 2010
The Boston Keratoprosthesis: Comparing Tissue Compatibility of Titanium and PMMA.
Ament, J.D., Spurr-Michaud, S., Gipson, I.K., Dohlman, C.H.; Cornea 2009
Idiopathic Intracranial Hypertension: A Neurosurgical Perspective.
Ament JD, Hoffman C, Black PM.; Neurosurgery Quarterly 2007
Meningioma and NF2: A Review.
Hoffman, C., Ament, J.D., Black, P.M.; Neurosurgery Quarterly 2007
Health impact and economic analysis of NGO-supported neurosurgery in Bolivia.
Ament, J. D., Greene, K. R., Flores, I., Capobianco, F., Salas, G., Uriona, M. I., Weaver, J. P., Moser, R.
Cost-effectiveness of The Boston Keratoprosthesis
Ament, J.D., Stryjewki, T.P., Chodosh, J., Dohlman, C.H.; Am J Ophthalmol. 2010
Cost Utility Analysis of the Cervical Artificial Disc vs Fusion for the Treatment of 2-Level Symptomatic Degenerative Disc Disease: 5-Year Follow-up.
Ament, J. D.,Yang, Z.,Nunley, P.,Stone, M. B.,Lee, D.,Kim, K. D.
A Novel Quality of Life Utility Index in Patients with Multilevel Cervical Degenerative Disc Disease: Comparison of Anterior Cervical Discectomy and Fusion with Total Disc Replacement.
Jared D. Ament, Zhuo Yang, Yingjia Chen, Ross S. Green, Kee D. Kim
Standardizing cost-utility analysis in neurosurgery.
Ament, J. D.,Kim, K. D.
Cost-effectiveness of cervical total disc replacement vs fusion for the treatment of 2-level symptomatic degenerative disc disease.
Ament, J. D., Yang, Z., Nunley, P., Stone, M. B., Kim, K. D.
Understanding United States Investigational Device Exemption Studies-Clinical Relevance and Importance for Healthcare Economics.
Ament, J. D.,Mollan, S.,Greenan, K.,Binyamin, T.,Kim, K. D.> ;Neurosurgery. 2017 Apr 04
Cost-effectiveness of a bone-anchored annular closure device versus conventional lumbar discectomy in treating lumbar disc herniations.
Ament, J.,Yang, Z., Thaci, B., Kulubya, E., Hsu, W., Bouma, G., Kim, K. D.; Spine (Phila Pa 1976) 2019